Colloquium "Challenges in drug and vaccine research: Targeting SARS-CoV-2"

Nov 25
25. November 2020 10:00 Uhr bis 18:00 Uhr
Prof. Klaus Überla, Uniklinikum Erlangen | online

The research training grant GRK2504 (speaker: Prof. Klaus Überla) at the Friedrich-Alexander-Universität Erlangen-Nuremberg aims to explore novel approaches for antiviral chemotherapy and immune intervention. The research training grant is funded by Deutsche Forschungsgemeinschaft (DFG) and includes a collaboration with the Ragon Institute of MGH, MIT and Harvard, Boston, USA.

Confirmed speakers are:

• Prof. Dr. Hans-Martin Jäck (Division of Immunolgy, Department of Medicine 3, Universitätsklinikum Erlangen)

• PD Dr. Dr. Anita Kremer (Medizin 5, Universitätsklinikum Erlangen)

• Prof. Dr. Manfred Marschall (Institute of Clinical and Molecular Virology, Universitätsklinikum Erlangen)

• Dr. Nadine Salisch (Viral Vaccines, Janssen Vaccines & Prevention B.V., Den Haag, Netherlands)

• Prof. Dr. Robin Shattock (Mucosal Infection and Immunity, Department of Medicine, Imperial College, London, England)

• Prof. Dr. Gerd Sutter (Institute for Infectious Diseases and Zoonoses, Ludwig-Maximilians-Universität Munich)

• Prof. Dr. Matthias Tenbusch (Institute of Clinical and Molecular Virology, Universitätsklinikum Erlangen)

• Dr. Jens Vollmar (Medizinischer Fachbereich Impfstoffe, Reise- und Tropenmedizin, GlaxoSmithKline GmbH & Co. KG, Munich)

• Prof. Dr. Ralf Wagner (Institute of Medical Microbiology and Hygiene, University of Regensburg)

Password: 250420
Please log in with your real name and switch off camera and microphone!